Literature DB >> 754481

Absorption, distribution and elimination of drotaverine.

K Magyar, M Lengyel, J Knoll.   

Abstract

14C-drotaverine [1(3',4'-diethoxybenzale)-6, 7-diethoxy-1, 2,3, 4-tetrahydroisoquinoline. HCl; No-SpaR] is well absorbed after subcutaneous and oral administration in mice. Its distribution is not specific. After intravenous administration the drug penetrates rapidly into every organ as indicated by whole body autoradiography. In the first hours the concentration of drotaverine was higher in the intestinal wall than in the other tissues. The concentrations of drotaverine in the organs decrease soon after administration and the drug is excreted mainly with the bile as beta-glucuronide; 60% of the dose was in the bile collected during 5 hours. During 96 hours of observation, 67% of the radioactivity administered was found in the stools while only 20% of it was eliminated with urine.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 754481

Source DB:  PubMed          Journal:  Acta Physiol Acad Sci Hung        ISSN: 0001-6756


  5 in total

1.  The intestinal absorption and excretion of 14C drotaverin in rats.

Authors:  G Simon; Z Vargay; M Winter; T Szüts
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

2.  Qualitative and quantitative determination of drotaverine metabolites in rat bile.

Authors:  Z Vargay; G Simon; M Winter; T Szüts
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

3.  Pharmacokinetics and bioavailability of drotaverine in humans.

Authors:  O O Bolaji; C O Onyeji; A O Ogundaini; T A Olugbade; F A Ogunbona
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Jul-Sep       Impact factor: 2.441

4.  The fate of drotaverine-acephyllinate in rat and man. I. Absorption, distribution and excretion in the rat.

Authors:  I Szatmári; G Simon; Z Vargay; E Tóth; T Szüts
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Jan-Mar       Impact factor: 2.441

5.  The fate of drotaverine-acephyllinate in rat and man. II. Human pharmacokinetics of drotaverine-14C-acephyllinate.

Authors:  Z Vargay; T Deutsch; I Szatmári; T Szüts; P Várkonyi; S Kerpel-Fronius; S Eckhardt
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Jan-Mar       Impact factor: 2.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.